Clinical Trials · NCT06066528
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 755
- Start date
- Nov 2023
- Locations
- 143 sites, 19 countries
- Primary endpoint
- Percentage change in body weight from baseline to Week 76